A detailed history of Livforsakringsbolaget Skandia, Omsesidigt transactions in Iqvia Holdings Inc. stock. As of the latest transaction made, Livforsakringsbolaget Skandia, Omsesidigt holds 233 shares of IQV stock, worth $48,186. This represents 0.0% of its overall portfolio holdings.

Number of Shares
233
Previous 233 -0.0%
Holding current value
$48,186
Previous $53,000 9.43%
% of portfolio
0.0%
Previous 0.01%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Nov 14, 2022

SELL
$181.14 - $248.26 $144,912 - $198,608
-800 Reduced 77.44%
233 $42,000
Q2 2022

Aug 16, 2022

SELL
$196.45 - $252.29 $78,580 - $100,916
-400 Reduced 27.91%
1,033 $224,000
Q4 2021

Feb 14, 2022

SELL
$238.37 - $282.61 $214,533 - $254,349
-900 Reduced 38.58%
1,433 $404,000
Q3 2021

Oct 28, 2021

SELL
$239.54 - $265.23 $143,724 - $159,138
-600 Reduced 20.46%
2,333 $559,000
Q4 2020

Mar 02, 2021

BUY
$153.99 - $180.39 $200,187 - $234,506
1,300 Added 79.61%
2,933 $526,000
Q3 2020

Nov 09, 2020

SELL
$141.28 - $169.75 $127,152 - $152,775
-900 Reduced 35.53%
1,633 $257,000
Q2 2020

Jul 08, 2020

BUY
$100.04 - $153.06 $80,032 - $122,448
800 Added 46.16%
2,533 $359,000
Q1 2020

Apr 22, 2020

BUY
$84.0 - $166.11 $33,600 - $66,444
400 Added 30.01%
1,733 $187,000
Q4 2019

Jan 28, 2020

SELL
$137.59 - $155.95 $82,554 - $93,570
-600 Reduced 31.04%
1,333 $206,000
Q2 2019

Jul 19, 2019

BUY
$132.28 - $160.9 $66,140 - $80,450
500 Added 34.89%
1,933 $311,000
Q3 2018

Oct 26, 2018

SELL
$99.3 - $130.77 $148,950 - $196,155
-1,500 Reduced 51.14%
1,433 $186,000
Q2 2018

Jul 10, 2018

BUY
$94.85 - $105.95 $75,880 - $84,760
800 Added 37.51%
2,933 $293,000
Q4 2017

Jan 18, 2018

BUY
$95.0 - $108.56 $202,635 - $231,558
2,133
2,133 $209,000

Others Institutions Holding IQV

About IQVIA HOLDINGS INC.


  • Ticker IQV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 185,740,000
  • Market Cap $38.4B
  • Description
  • IQVIA Holdings Inc. provides advanced analytics, technology solutions, and clinical research services to the life sciences industry in the Americas, Europe, Africa, and the Asia-Pacific. It operates through three segments: Technology & Analytics Solutions, Research & Development Solutions, and Contract Sales & Medical Solutions. The ...
More about IQV
Track This Portfolio

Track Livforsakringsbolaget Skandia, Omsesidigt Portfolio

Follow Livforsakringsbolaget Skandia, Omsesidigt and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Livforsakringsbolaget Skandia, Omsesidigt, based on Form 13F filings with the SEC.

News

Stay updated on Livforsakringsbolaget Skandia, Omsesidigt with notifications on news.